Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India

• المؤلفون الرئيسيون: Juan Eduardo Resendiz-Galvan (مؤلف), Prerna R. Arora (مؤلف), Mahmoud Tareq Abdelwahab (مؤلف), Zarir F. Udwadia (مؤلف), Camilla Rodrigues (مؤلف), Amita Gupta (مؤلف), Paolo Denti (مؤلف), Tester F. Ashavaid (مؤلف), Jeffrey A. Tornheim (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Linezolid is an oxazolidinone used to treat multidrug-resistant tuberculosis (MDR-TB), including in the recently-endorsed shorter 6-month treatment regimens. Due to its narrow therapeutic index, linezolid is often either dose-adjusted or discontinued due to intolerance or toxicity during treatment,...